- Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer
-
Lee D, Choi J, Oh HJ, Ham IH, Lee SH, Nomura S, Han SU, Hur H
- KMID: 2538002
- Cancer Res Treat.
- 2023 Jan;55(1):167-178.
- doi: 10.4143/crt.2022.094
Purpose Appropriate preclinical mouse models are needed to evaluate the response to immunotherapeutic agents. Immunocompetent mouse models have rarely been reported for gastric cancer. Thus, we investigated immunophenotypes and responses... -
- CITED
-
- Close
- SHARE
-
- Close
